MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gamma-aminobutyric acid(GABA)"

  • 2022 International Congress

    Electrophysiological correlates of neurological deficits in toxic-metabolic encephalopathy

    N. Prezelj, K. Vogelnik, B. štabuc, M. Kojovic (Ljubljana, Slovenia)

    Objective: We used transcranial magnetic stimulation (TMS) paradigms reflecting GABAA, GABAB, cholinergic and glutamatergic transmission at the motor cortex level, to investigate pathophysiology of different…
  • 2019 International Congress

    Changes in GABAergic transmission of striatal neurons in presymptomatic Huntington’s Disease

    M. Treven, F. Zirpel, I. Mody (Vienna, Austria)

    Objective: To determine whether parameters of synaptic and extrasynaptic GABAergic inhibition of striatal projection neurons are altered in presymptomatic BACHD mice. Background: One attractive early…
  • 2019 International Congress

    GABA-A Receptor Positive Allosteric Modulators: Phase 2 Proof of Concept Studies of Brexanolone Injection and SAGE-217 in Essential Tremor

    J. Paskavitz, A. Bullock, D. Nguyen, A. Smith, B. Farley, M. Quirk, I. Kaul, S. Li, A. Ellenbogen, C. Silber, J. Doherty, H. Colquhoun, S. Kanes (Cambridge, MA, USA)

    Objective: To examine use of γ-aminobutyric acid (GABA) type A receptor (GABA-A-R) positive allosteric modulators (PAMs) in the treatment of essential tremor (ET) in early…
  • 2019 International Congress

    Activity of Neurosteroid GABAA Positive Allosteric Modulators in Preclinical Harmaline Model for Essential Tremor

    R. Hammond, A. Robichaud, J. Doherty, F. Salituro, M. Quirk, M. Ackley, B. Farley, S. Mctighe, T. Kazboda, A. Althaus, C. Maciag, M. Blanco, S. Gee (Cambridge, MA, USA)

    Objective: The objective of the present study was to test the activity of neurosteroid (NAS) GABAA positive allosteric modulators, including novel synthetic NAS SGE-516, at…
  • 2019 International Congress

    A Case of Pregabalin induced Parkinsonism

    BC. Ari, F. Mayda Domac, G. Ozgen Kenangil (Istanbul, Turkey)

    Objective: Present a case of parkinsonism after administration of pregabalin, a rare case Background: Drug induced parkinsonism is the second common movement disorders after Parkinson’s…
  • 2018 International Congress

    Ocular motor function in stiff person syndrome – Role of GABA and beyond

    F. Wang, L. Neilson, H. Wang, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

    Objective: Delineate pathophysiology of gaze-holding function in stiff person syndrome (SPS). Background: Glutamic acid decarboxylase (GAD) catalyzes conversion of glutamate to gamma-aminobutyric acid (GABA). Anti-GAD…
  • 2018 International Congress

    Intrathecal baclofen (ITB) therapy in the treatment of severe spasticity: Safety and Product Performance from a Large Multinational Multi-Center Registry

    M. Schiess, S. Eldabe, R. Spencer, K. Stromberg, T. Weaver, R. Plunkett (Houston, TX, USA)

    Objective: •To use real-world registry data to augment available safety data, product performance and support overall efficacy. •To utilize registry data to broaden awareness of…
  • 2018 International Congress

    Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats

    S. Singh (Moga, India)

    Objective: (1) Curcumin is well tolerated curcuminoid used as supplement for various disorders but problem is its low oral bioavailability. (2) Piperine is combined to…
  • 2016 International Congress

    Neuroprotective potential of L-theanine against excitotoxic neuronal death induced by quinolinic acid: Possible neurotransmitters and nitric oxide modulation mechanism

    S. Jamwal, P. Kumar (Moga, India)

    Objective: To evaluate the neuroprotective efficacy of L-theanine, an unique amino acid with neuroprotective properties, for its beneficial potential if any, in quinolinic acid induced…
  • 2016 International Congress

    Dysregulations of GABAergic neurotransmission in Huntington’s disease brain

    Y.T. Hsu, Y.G. Chang, H.M. Chen, Y. Chern (Taichung, Taiwan)

    Objective: To investigate (1) the expression of GABAA receptors and KCC2 in both Huntington's disease (HD) mouse models and patients and (2) the inhibitory effect…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley